Sanofi-Aventis Denies It Offered Genzyme a Price Range at Sept. 20 Meeting

Sanofi-Aventis SA denied that it offered Genzyme Corp. a price range in a Sept. 20 meeting between the chief executives of the companies.

“We offered no price range,” Sanofi spokesman Jean-Marc Podvin said by telephone.

To contact the editor responsible for this story: David Whitehouse at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.